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Abstract
Background: To investigate the clinicopathological features of six cases of soft tissue recurrent ameloblastoma 
and explore the role of increased aggressive biological behavior in the recurrences and treatment of this type of 
ameloblastomas. 
Material and Methods: In this study, we retrospectively reviewed recurrent ameloblastomas during a 15-year pe-
riod; six cases were diagnosed as soft tissue recurrent ameloblastoma. The clinical, radiographic, cytological and 
immunohistochemical records of these six cases were investigated and analyzed. 
Results: All the six soft tissue recurrent ameloblastomas occurred after radical bone resection, and were located 
in the adjacent soft tissues around the osteotomy regions. In Case 4, the patient developed pulmonary metastasis, 
extensive skull-base infiltration and cytological malignancy after multiple recurrences and malignant transfor-
mation was diagnosed. In the other five cases, although there were no cytological signs are sufficient to justify 
an ameloblastoma as malignant, some malignant features were observed. In Case 1, the tumor showed moderate 
atypical hyperplasia and the Ki-67 staining percentage was 40% positive, which are strongly suggestive of po-
tential malignance. In Case 5, the patient developed a second soft tissue recurrence in the parapharyngeal region 
and later died of tumor-related complications. All the remaining three patients showed cytology atypia of varying 
degrees and high expression of PCNA or Ki-67, which confirmed active cell proliferation. 
Conclusions: Increased aggressiveness is an important factor of soft tissue recurrence. An intraoperative rapid 
pathological examination and more radical treatment are suggested for these cases.
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Introduction
Ameloblastoma is the most common epithelial odon-
togenic tumor, and it accounts for 10% of all tumors 
that arise in the mandible and maxilla (1). Ameloblas-
toma is generally considered to be a benign lesion with 
locally invasive behavior and a tendency to reoccur af-
ter inadequate treatment (2-4). The risk of recurrence 
is reported to be significantly reduced by radical treat-
ment compared to conservative surgical treatment (5,6). 
However, there are some reports of soft tissue recurrent 
ameloblastomas after radical treatment too. Olaitan ret-
rospectively reviewed 26 cases of recurrent ameloblas-
toma within a 15-year period, and reported that four in-
traosseous ameloblastomas recurred in the soft tissues 
of the head and neck (3). Adebayo et al. described a case 
of soft issue recurrence in the chin 21 years after radical 
resection of an ameloblastoma of the mandible (7). 
Recurrence ameloblastoma due to inadequate treatment 
is often emphasized in literatures; however, the mecha-
nism of recurrence could be quite complex due to their 
highly variable biological behaviors. Ameloblastoma 
recurrence has been suggested to be correlated to both 
the type of surgical treatment and increased aggressive 
biological behavior (8). Ameloblastomas constitute a 
group of heterogeneous lesions that exhibit rather vari-
able biological behaviors ranging from cystic expansion 
to aggressive solid mass formation and even malignant 
transformation (1). Furthermore, ameloblastomas oc-
casionally demonstrate clinical course characteristic 
of malignancies and may be associated with significant 
morbidity and sometimes death (9). The World Health 
Organization (WHO) has classified ameloblastomas 
into the following variants: solid/multicystic ameloblas-
toma, unicystic ameloblastoma, desmoplastic amelob-
lastoma and peripheral ameloblastoma, as well as ma-
lignant counterparts such as malignant ameloblastoma 
and ameloblastic carcinoma (10). Moreover, there are 
atypical ameloblastomas that showed cytology atypia 
but could not be classified as malignant ameloblastoma 
or ameloblastic carcinoma (11). 
In this study, we retrospectively reviewed recurrent 
ameloblastomas during a 15-year period (1998-2013), 
six soft tissue recurrent ameloblastomas were diag-
nosed of 25 recurrent ameloblastomas. The soft tissue 
recurrent ameloblastomas which occurred after radical 
bone resection and located in the adjacent soft tissues 
and without involvement of the residual jaw, showed 
clincopathologcial features which were not quite con-
sistent with intraossous recurrent ameloblastomas. The 
role of increased aggressive biological behavior in the 
recurrences and treatment are discussed in this paper. 
Material and Methods
We retrospectively reviewed the clinical data of amel-
oblastoma patients admitted to our hospital who under-
went resection and had histopathologically confirmed 
recurrent ameloblastoma during 1998-2013. Of the 25 
recurrent ameloblastomas, six cases were diagnosed 
as soft tissue recurrent ameloblastomas based on their 
clinical, radiographic and histological presentations. Of 
these six cases, three cases had multiple recurrences: 
Case 4 showed six recurrences during 1998-2013; cases 
5, two recurrences during the period of study, and Case 
6, had recurrences in 1992 and 1996 respectively. The 
following clinical data of the six recurrent cases were 
recorded for the six soft tissue recurrence cases: sex, 
age at presentation of recurrence, site of recurrence, 
time interval between primary operation and recur-
rence, number of recurrences, types of surgery and 
follow-up reviews. 
Histopathological sections of the primary and recur-
rent lesions were collected and evaluated for the his-
topathologic type and presence of cytology atypia. The 
histopathologic classifications included follicular, plexi-
form, acanthomatous, granular, basal cell type, and 
keratoameloblastoma (4,12). The cytological atypic fea-
tures included hypercellularity, pleomorphism, hyper-
chromatic nuclei, and presence of mitotic figures (13). 
Immunohistochemical examination for the quantitative 
expression of Ki-67 or semi-quantitative expression (-, 
+ or ++) of antigen proliferating cell nuclear antigen 
(PCNA) was conducted in all the six recurrent cases 
(14,15).
All patients gave their written informed consent.
This study was approved by the Ethics Committee of 
the Affiliated Stomatology Hospital of Medical School, 
Nanjing University.
Results
The clinical and pathological data of the six intraos-
seous ameloblastomas with soft tissue recurrence are 
shown in table 1. 
- Basal clinical data for recurrences
Four men and two women with soft tissue recurrent 
ameloblastoma were investigated in this study. The 
mean age at presentation of recurrence was 52.5 years 
(range, 37-70 years). The average time interval between 
the primary operation and recurrence was 22.3 years 
(range, 7-40 years). With the exception of Case 4, the 
time interval between the primary operation and the re-
currences was ≥10 years in the remaining five cases. 
- Type of primary surgery 
In Case 4, enucleation and curettage were performed for 
the primary maxillary ameloblastoma; further, radical 
bone resection (partial maxillectomy) was performed 
for the first recurrence 2 years later. In the other five 
cases, radical bone resection was performed for all the 
primary lesions: hemimandibulectomy in three cases, 
segmental resection in one case and resection of the le-
sion with the dentoalveolar segment and preservation 
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of the lower border in one case. In two cases, osseous 
reconstruction was performed for the defects. 
- Location of the recurrent tumors
In three cases, the recurrent tumors were located in the 
submandibular region on the same side of the primary 
lesion; in one case, it was located in the soft tissue of the 
osteotomy region; and in two cases, the tumors recurred 
in the gingival tissue of the molar regions. 
- Follow-up review
In all six cases, extensive tumor excision was performed 
for the recurrent tumors to prevent further recurrences. 
The follow-up time was 2-10 years, and in four cases, 
there were no additional recurrences after that. How-
ever, in Case 4, the patient developed pulmonary metas-
tasis and extensive skull-base infiltration after multiple 
recurrences and died in 2013; in Case 5, the patient de-
veloped a second soft tissue recurrence in the parap-
haryngeal region, but he refused further treatment and 
died not long after that due to complications caused by 
the tumor. 
- Radiographic features
In all the six cases, all the primary lesions showed exten-
sive bone destruction involving the cortical plate. With 
regard to the soft tissue recurrences, all the bone margins 
were totally intact and without signs of bone recurrence.
- Histopathological features
Of the six cases, four were of the follicular type; one was 
plexiform type and one, basal cell type. All the six pa-
tients presented with cytology atypia of varying degrees 
for both the primary lesions and recurrent lesions (13). 
In Case 4, the primary lesion showed hypercellularity 
and the fifth recurrent tumor demonstrated increased 
cytological malignancy with hypercellularity, hyper-
chromatic nuclei, cellular and nuclear pleomorphism, 
increased mitotic figures, and focal areas of necrosis. 
In the other five cases, there were no significant signs 
indicating malignant transformation (ameloblastic car-
cinoma ex-ameloblastoma). In Case 1 and Case 2, the 
percentage of Ki-67-positive cells was 40% and 32% re-
spectively. The other four cases were positive for PCNA 
(+ in two cases, and ++ in two cases). 
- Case Reports 
- Case 1
The patient was 22 years old at the time of the initial 
diagnosis of ameloblastoma in 1994. Resection of the 
lesion with dentoalveolar segment and preservation of 
the lower border was performed. Eighteen years later, 
the patient developed an intraoral swelling in the right 
mandibular body. CT revealed a soft tissue mass in the 
osteotomy region with an intact bone defect (Fig. 1A 
and 1B). Thereafter, extensive resection of the tumor 
and lower border of the jaw and transplantation of the 
ribs and fibula were performed. The final histological 
classification was recurrent follicular ameloblastoma. 
The patient has been followed up continuously with no 
evidence of recurrence. In the case of the recurrent tu-
mor, moderate atypia was detected but it was not enough 
to justify an ameloblastic carcinoma. Moreover, the Ki-
67 staining percentage was 40% which confirmed ac-
tive cell proliferation (Fig. 1C and 1D). Further, retro-
spective evaluation of the histopathological sections of 
primary lesion also showed cytology atypia including 
Case No. 1 2 3 §4 *5 6 
Gender M F M M M F
Age (years) 40 70 63 37 57 48
Time interval (years)  18 40 33 7 24 12
No. of recurrences 1 1 2 6 2 1
Primary  treatments 2 4 3+5 5 4 4+5
Site of recurrence L M (osteotomy region) 
L
SM
L
M
R
SM
R
SM
L
M
Pathological
classification Follicular Plexiform Follicular Basal cell Follicular Follicular
Cytological features HC,HN, PM, MF 
HC, HN, 
MF HC, HN 
HC, HN, 
MF 
HC, HN, 
MF 
HC,HN, 
MF 
Ki-67 40% 32% / / / / 
PCNA / / + ++ ++ + 
Table 1. Clinical, pathological and immunohistochemical findings of six soft tissue recurrent ameloblastoma cases.
Primary treatments in this study are divided into five types: 1: Curettage and enucleation, 2: Resection of the lesion with the 
dentoalveolar segment and preservation of the lower border; 3: Segmental resection; 4: Hemimandibulectomy and hemimaxil-
lectomy 5: Osseous reconstruction. 
Site of recurrence: L: Left; R: Right; M: Molar region; SM: Submandibular region.
Cytological features: HC: Hypercellularity; HN: Hyperchromatic nuclei; PM: Pleomorphism; MF: Mitotic figures.
§Case 4 had multiple recurrences and in the table was the fifth recurrence.
*Case 5 had two soft tissue recurrences, but the patient refused further treatment for the second recurrence. The table provides 
information about the first recurrence.
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hypercellularity, hyperchromatic nuclei and pleomor-
phism (Fig. 1E). 
- Case 2
The female patient was 30 years old at the time of the 
initial diagnosis of ameloblastoma, and hemimand-
ibulectomy was performed in 1979. Thirty years later, 
the patient developed a swelling in the submandibular 
region. CT revealed a soft tissue mass with a totally in-
tact bone defect. Extensive resection of the tumor was 
performed, and the histological diagnosis was recurrent 
ameloblastoma. The Ki-67 staining percentage was 32% 
positive for the recurrent ameloblastoma. Retrospective 
evaluation of the histopathological sections of both the 
primary and recurrent lesion showed plexiform amelob-
lastoma with cytology atypia including hypercellular-
ity, hyperchromatic nuclei and mitotic figures.
- Case 3
The patient was 30 years old at the time of the ini-
tial diagnosis of ameloblastoma in 1973. In 1992 and 
2006, the patient had soft tissue recurrences located in 
the buccal mucosa and mandibular retromolar pad re-
spectively. Extensive resections were performed for the 
recurrent tumors and the patient has been followed up 
with no evidence of recurrence. The histopathological 
classification was follicular ameloblastoma and cytol-
ogy atypia was found for the primary lesions and two 
times of recurrent lesions.
- Case 4 
The patient was referred to our hospital and underwent 
total enucleation and curettage for maxillary amelob-
lastoma in 1999 (Fig. 2A). Histological examination 
showed a follicular ameloblastoma with slight cytology 
atypia. In 2001, the patient developed his first recurrence 
and a partial maxillectomy was performed. Following 
this, the patient had two more soft tissue recurrences in 
2002 and 2004, and radical resection was performed on 
both occasions. All three recurrent tumors were treated 
at another hospital. In 2006, the patient was admitted to 
our hospital again with a soft tissue recurrence in the 
right pterygomaxillary fossa (Fig. 2B) and extensive 
tumor excision was performed. In 2007, the patient pre-
sented once again with recurrent ameloblastoma in the 
right submandibular region (Fig. 2C). And a thoracic 
CT examination indicated pulmonary metastasis (Fig. 
Fig. 1. Radiographic, histological and immunohistochemical findings in Case 1.  A: Panoramic radiograph showing a rectangular resection in 
the dentoalveolar side of the right mandible. B: Spiral CT image showing a soft tissue mass in the bone defect region (star). C: Pathological speci-
men of the recurrence showing moderate cellular atypia: hypercellularity, hyperchromatic nuclei, pleomorphism and mitotic figures (arrow). 
(hematoxylin and eosin staining; original magnification, ×400). D: Strong positive staining of the nuclei is seen in the tumor cells (Ki-67, arrow; 
×100). E: Histopathological appearance of the primary lesion revealed hypercellularity, hyperchromatic nuclei and pleomorphism (hematoxylin 
and eosin staining; original magnification, ×200).
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2D). Extended tumor excision from the submandibular 
space was performed. Histological examination of the 
submandibular tumor specimen demonstrated cyto-
logical malignancy with hypercellularity, hyperchro-
matic nuclei, cellular and nuclear pleomorphism, and 
increased mitotic figures (Fig. 2E). In 2008, the patient 
had the sixth recurrence that manifested as numbness 
of the right face. Craniofacial CT revealed infiltration of 
the skull-base, including the petrous bone (Fig. 2F). The 
patient did not undergo further treatment and died in 
2013. Based on the entire aggressive clinic course and 
cytological progression, malignant transformation was 
diagnosed.
- Case 5
The patient was 33 years old at the time of the initial 
diagnosis in 1982 and hemimandibulectomy was per-
formed for the primary lesion (Fig. 3A). Twenty-four 
years later, the patient developed a painful swelling in the 
right submandibular region with significant aggravation 
in a short time. Extra-oral examination revealed adhe-
sion of a mass to the skin in the submandibular region. A 
panoramic radiograph revealed that the bone margin was 
completely intact (Fig. 3B). Extensive tumor resection 
was performed, and histological examination confirmed 
soft tissue recurrent ameloblastoma (follicular). Cytology 
atypia was confirmed for both the primary and recurrent 
lesions, based on the observed hypercellularity, hyper-
chromatic nuclei and mitotic figures (Fig. 3C, 3D). One 
year later, the patient developed a second recurrence in 
the parapharyngeal region (Fig. 3E), but he refused fur-
ther treatment and died not long after that. 
- Case 6
The patient was 36 years old at the time of the initial di-
agnosis of ameloblastoma in 1989; hemimandibulectomy 
and osseous reconstruction were performed. Twelve 
years later, the patient developed a soft tissue recurrence 
in the mandibular third molar region. The final histologi-
cal classification was recurrent follicular ameloblastoma. 
Similar with the other cases, retrospective cytological 
evaluation of the histopathological sections for the pri-
mary and recurrent lesion showed cytology atypia in-
cluding hypercellularity and hyperchromatic nuclei.
 
Discussion
According to the present classification of ameloblas-
toma, the benign ameloblastomas are divided into 
Fig. 2. Radiographic and histological findings in Case 4. A: Panoramic radiograph from February 1999 showing a well-defined mul-
tilocular radiolucent shadow located from the second premolar to the maxillary tuberosity (arrow); B: Scan from 2006 showing an 
irregular soft-tissue density mass in the right pterygomaxillary fossa (star). C: Spiral CT images taken in 2007 showing soft tissue 
recurrences (star) behind the right submandibular gland. D: The specimen from 2007 depicting a region of cytology atypia with mitotic 
figures (arrows) and hyperchromatic nuclei (hematoxylin and eosin staining; original magnification, ×400). E: Thoracic CT images 
showing multiple nodules in both lung fields (arrows). F: Spiral CT images taken in 2008 showing erosion of the right petrosal apex of 
the temporal bone and the cranial base surface of the sphenoid bone with a diffuse boundary (arrow). 
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1) solid/multicystic, 2) extra-osseous/peripheral, 3) 
desmoplastic, and 4) unicystic ameloblastoma. The 
solid/multicystic ameloblastomas are more aggressive 
than other types because they carry a high risk of local 
recurrences after inadequate treatment (1,4). Malignant 
ameloblastic lesions are divided into malignant (metas-
tasizing) ameloblastoma and ameloblastic carcinoma. 
Malignant ameloblastoma describe an ameloblastoma 
with distant metastasis, and both primary and meta-
static tumors retain a benign histological appearance. 
Ameloblastic carcinomas are tumors that combined 
morphologic features of ameloblastoma and carcinoma, 
regardless of the presence or absence of metastasis (13). 
However, ameloblastomas are on a complex spectrum 
of a single disease, there are atypical subtypes which 
presenting anaplastic features not sufficient to justify 
an ameloblastoma as malignant, but it carries increased 
aggressive biological behavior. In this study, some ma-
lignant features were observed for these cases at var-
ied degrees. In case 4, pulmonary metastasis, extensive 
skull base infiltration and increased cellular atypia 
were found after multiple recurrences, and malignant 
transformation was diagnosed. However, in the other 
five cases, although there were no significant signs in-
dicating ameloblastic carcinoma in both the primary 
and recurrent tumors, varying degrees of cellular atypia 
including hypercellularity, hyperchromatic nuclei, pleo-
morphism, and mitotic figures were observed (13). High 
expression of Ki-67 or PCNA was also found, which 
confirmed active cell proliferation (14,15). In Case 1, 
moderate atypical hyperplasia and 40% positive stain-
ing for Ki-67 were observed, which is strongly sugges-
tive of potential malignance (11,12,14). In Case 5, the 
patient developed a second recurrence in the parapha-
ryngeal region and died of tumor-related complications. 
In all the remaining three cases, the tumors showed cy-
tology atypia and high expression of PCNA or Ki-67, 
which confirmed active cell proliferation. 
Ameloblastoma recurrence has been suggested to be 
correlated to both the histological features and the type 
of surgical treatment (8). It is known that ameloblas-
tomas may recur from tumor tissue remaining in the 
residual stump of the jaw, from adjacent soft tissues, 
or from intraoperative contamination (16). However, in 
the present cases, tumors remaining in the stump of the 
jaw are less likely to recur because of the intact bone 
Fig. 3. Radiographic and histological findings in Case 4.  A: Lateral mandible radiograph from 1978 showing a multilocular radiolucent shadow 
spreading from the mandibular body to the ramus. B: Soft tissue recurrence in the submandibular region in 2002; the panoramic radiograph 
shows an intact bone margin of the mandible. C: Spiral CT scan from 2003 showing a second soft tissue recurrence in the right pterygomaxil-
lary fossa (star). D and E: Histopathological appearance of the tumor in 1978 and 2002 depicting regions of cellular atypia with hypercellularity, 
hyperchromatic and nuclei mitotic figures (arrows) (hematoxylin and eosin staining; original magnification, ×400).
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and recurrences occurring in the soft tissues around 
the osteotomy region. Moreover, although en-bloc bone 
resections had been performed before the soft tissue re-
currences in all the cases, intraoperative contamination 
cannot be ignored; therefore, intraoperative contamina-
tion could have been a cause of tumor recurrence in the 
present cases. Nonetheless, it seems that residual tumor 
in adjacent soft tissue was the main cause of recurrence 
in the cases investigated in the present study. The soft 
tissue recurrent tumors in our study were aggressive, and 
the pre-surgical radiograph of the primary lesion showed 
destruction of the cortical plate and possible infiltration 
into the adjacent soft tissues. However, the high level of 
aggressiveness of the lesions was not noted at the time of 
surgery, and only radical bone resection was performed 
in all cases. Thus, from the present findings, it can be 
speculated that insufficient resection of adjacent soft tis-
sue in the primary treatments and presence of residual tu-
mor tissue in the adjacent soft tissues are the most likely 
causes of recurrence; this is in agreement with the obser-
vation of other published studies (17,18).
Considering the highly aggressive nature of these atypi-
cal ameloblastomas, firstly, a preoperative radiographic 
evaluation of whether the tumor involves the cortical 
plate is required, as destruction of the cortical plate sug-
gests possible infiltration into the adjacent soft tissues. 
Secondly, a frozen rapid pathological examination dur-
ing the surgery is suggested for these ameloblastomas 
cases; if cytological atypia indicative of aggressiveness 
is observed, more radical treatment including clearance 
of at least one more layer of tissue around such lesions 
should be performed (18). Moreover, for soft tissue re-
current ameloblastomas, a more radical treatment with 
enough safe margins is important to avoid secondary 
recurrences. Therefore, pathological examination of the 
resection edge is necessary for confirming the resection 
boundary in these cases. 
It has also been reported that 50–80% of ameloblastoma 
recurrences are diagnosed within the first 5 years (2-4). 
However, in this study, late recurrence was found in five 
patients for whom the time interval between the primary 
operation and recurrence was ≥10 years; in agreement 
with this, late recurrences have been reported in some 
recent studies (7). Eckardt reported that the rate of cu-
mulative relapses was 17% after 5 years and 19% after 
10 years (6). Therefore, a long-term follow-up beyond 5 
years is required, especially in cases where the tumors 
are of an aggressive nature. 
Conclusions
In this clinical retrospective study of recurrent amelob-
lastomas during a 15-year database (1998-2013), it was 
noted that soft tissue recurrence following radical bone 
resection also showed some malignant features. An intra-
operative rapid pathological examination and more radi-
cal treatment are suggested for these cases of aggressive 
tumors.
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